<div id="readability-page-1"><div><p>Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2025. These A-Shares will be under lockup for 2193 days starting from 24-SEP-2019 to 25-SEP-2025.</p><p>  Details:<br/> The Company's holding shareholder Guangdong Guanghui Investment Co., Ltd., actual controllers Lin Peiqing and Chen Qiong, and shareholders Gao Feng, Lin Peichun, Lin Qixiong, and Lin Peina have agreed not to dispose of their interest for a period of 36 months from the date of listing.</p><p>  The Company's shareholders Shantou Zhengnuo Investment Management Partnership Enterprise (Limited Partnership), Yao Zhuangmin, and Yang Rui have agreed not to dispose of their interest for a period of 12 months from the date of listing.</p><p>After the expiry of the lock-up period, the parties promise that yearly transfer of shares made by them will not exceed 25% of the holding, both direct and indirect, held by the present parties.</p></div></div>

仙乐健康

<p>某些仙乐健康的 A 股在锁定协议下，直到 2025 年 9 月 25 日，锁定期为 2193 天，自 2019 年 9 月 24 日起计算。主要股东，包括广东广汇投资有限公司等，承诺在上市后 36 个月内不处置其股份，而部分股东则有 12 个月的限制。锁定期结束后，年度股份转让将限制在其持股的 25% 以内</p>

仙乐健康有限公司的部分 A 股受到锁定协议的限制，该协议将于2025年9月25日到期